The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 30, 2021
Filed:
Mar. 21, 2017
Applicants:
Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;
Universite Paris Diderot-paris 7, Paris, FR;
Inventor:
Etienne Jacotot, Paris, FR;
Assignees:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), Paris, FR;
UNIVERSITE PARIS DIDEROT-PARIS 7, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A61P 27/02 (2006.01); A61P 9/10 (2006.01); A61P 25/28 (2006.01); A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61P 17/00 (2006.01); A61P 29/00 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61P 1/16 (2018.01); A61P 3/04 (2018.01); A61P 9/10 (2018.01); A61P 17/00 (2018.01); A61P 25/28 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); C07D 417/14 (2013.01);
Abstract
The present invention relates to a compound of formula (I) wherein P, P, Pand Pare amino acid residues. The invention also relates to a compound of formula (I) for its use as a Caspase-2 inhibitor and for its therapeutical use. It also concerns the use of a compound of formula (I) as activity base probe to selectively detect Caspase-2 activity.